ReviewRevista medica del Instituto Mexicano del Seguro Social2026
[Eosinophilic fascitis: A case report and literature review].
Review in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Eosinophilic fasciitis is a rare connective tissue disorder, characterized by inflammation and fibrosis of the deep fascia, with a heterogeneous clinical presentation and complex diagnosis. The objective was to describe a clinical case with a prolonged course, highlighting clinical, imaging, and histopathological features, as well as therapeutic response to combined immunosuppression. Clinical case: A 49-year-old woman presented with progressive skin sclerosis, painful subcutaneous nodules, severe lower limb edema, and functional limitation. MRI revealed fascial thickening and STIR hyperintensity. Deep biopsy showed intravascular fascitis, fibrosis, and chronic inflammatory infiltrate. Diagnosis of eosinophilic fasciitis was established and treatment with prednisone and methotrexate was initiated. After 20 months of follow-up, it was observed clinical improvement, resolution of edema, and reduced skin induration. Conclusions: Eosinophilic fasciitis can be confused with other scleroderma-like diseases, so early recognition and the use of specific diagnostic tools are essential. Combined treatment with corticosteroids and immunomodulators can induce remission and improve function, especially in cases with a prolonged course.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.